| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.13 | 0.7 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.031 | 0.7 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.029 | 0.7 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.11 | 0.7 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |